Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Screening and Article Selection Two independent researchers screened titles and abstracts of all retrieved studies based on the eligibility criteria
Lower risk of major cardiovascular events Clinical trials have shown that GLP-1 receptor agonists significantly reduce the risk of heart attack, stroke, and cardiovascular-related death in people with type 2 diabetes
Prevalence of small intestinal bacterial overgrowth in Parkinson's disease
Triozzi, M.D., an instructor in the Division of Nephrology and Hypertension and the studys first author, noted that these findings suggest GLP-1 receptor agonists could have broader kidney-protective effects that initially thought
US$ 28.67
US$ 28.04
US$ 29.38
US$ 23.31
US$ 28.08
US$ 28.85
US$ 28.36
US$ 28.57
US$ 28.86
US$ 29.66
US$ 28.27
US$ 21.06
US$ 26.35
